Page last updated: 2024-09-04

cyc 202 and Dyskinesia, Drug-Induced

cyc 202 has been researched along with Dyskinesia, Drug-Induced in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guan, Q; He, Y; Jin, L; Liu, X; Zhao, L	1

Other Studies

1 other study(ies) available for cyc 202 and Dyskinesia, Drug-Induced

Article	Year
Effect of cdk5 antagonist on L-dopa-induced dyskinesias in a rat model of Parkinson's disease. The International journal of neuroscience, 2010, Volume: 120, Issue:6 Topics: Animals; Antiparasitic Agents; Corpus Striatum; Cyclin-Dependent Kinase 5; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Phosphorylation; Protein Kinase Inhibitors; Purines; Random Allocation; Rats; Rats, Sprague-Dawley; Roscovitine; Severity of Illness Index; Treatment Outcome	2010

Article

Year

Effect of cdk5 antagonist on L-dopa-induced dyskinesias in a rat model of Parkinson's disease.

The International journal of neuroscience, 2010, Volume: 120, Issue:6

Topics: Animals; Antiparasitic Agents; Corpus Striatum; Cyclin-Dependent Kinase 5; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Dyskinesia, Drug-Induced; Female; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Phosphorylation; Protein Kinase Inhibitors; Purines; Random Allocation; Rats; Rats, Sprague-Dawley; Roscovitine; Severity of Illness Index; Treatment Outcome

2010